The Global Neoantigen Cancer Vaccine Therapy Market was valued at USD 986.00 Million in 2025 and is expected to reach USD 6,547.71 Million by 2033, growing at a CAGR of 26.7% (2026-2033).
The Global Neoantigen Cancer Vaccine Therapy Market was valued at USD 986.00 Million in 2025 and is expected to reach USD 6,547.71 Million by 2033, growing at a CAGR of 26.7% (2026-2033).
The Global Personalized Cancer Vaccines Market was valued at USD 234,790.00 Million in 2022 and is expected to reach USD 371,404.60 Million by 2030, growing at a CAGR of 5.9% (2023-2030).